Funder
Hartwell Foundation
U.S. Department of Health & Human Services | National Institutes of Health
Research to Prevent Blindness
Publisher
Springer Science and Business Media LLC
Subject
Computer Science Applications,Biomedical Engineering,Medicine (miscellaneous),Bioengineering,Biotechnology
Reference58 articles.
1. Urtti, A., Pipkin, J. D., Rork, G. & Repta, A. J. Controlled drug delivery devices for experimental ocular studies with timolol 1. In vitro release studies. Int. J. Pharm. 61, 235–240 (1990).
2. Hermann, M. M., Papaconstantinou, D., Muether, P. S., Georgopoulos, G. & Diestelhorst, M. Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring. Acta Ophthalmol. 89, E300–E305 (2011).
3. Agrawal, A. K., Das, M. & Jain, S. In situ gel systems as ‘smart’ carriers for sustained ocular drug delivery. Expert Opin. Drug Del. 9, 383–402 (2012).
4. Dumortier, G., Grossiord, J. L., Agnely, F. & Chaumeil, J. C. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res. 23, 2709–2728 (2006).
5. Rowe, R. C., Sheskey, P. J., Owen, S. C. & American Pharmacists Association. Handbook of Pharmaceutical Excipients 6th edn (Pharmaceutical Press, 2009).
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献